Five-year follow-up results of a randomized controlled trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate.

PURPOSE: To report the 5-year follow-up results of a randomized controlled trial comparing bipolar transurethral resection of the prostate (TURP) with standard monopolar TURP for the treatment of benign prostatic obstruction (BPO). MATERIALS AND METHODS: A total of 220 patients were randomized to bipolar plasmakinetic TURP (PK-TURP) or monopolar TURP (M-TURP). Catheterization time was the primary endpoint of this study. Secondary outcomes included operation time, hospital stay, as well as decline in postoperative serum sodium and hemoglobin levels. All patients were assessed preoperatively and followed-up at 1, 6, 12, 24, 36, 48, and 60 months postoperatively. Parameters assessed included quality of life, transrectal ultrasound, serum prostate-specific antigen level, postvoid residual urine volume, maximum urinary flow rates (Q(max)), and International Prostate Symptom Score. Patient baseline characteristics, perioperative data including complications, and postoperative outcomes were compared. Complication occurrence was graded according to the modified Clavien classification system. RESULTS: PK-TURP was significantly superior to M-TURP in terms of operation time, intraoperative irrigation volume, resected tissue weight, decreases in hemoglobin and sodium, postoperative irrigation volume and time, catheterization time, and hospital stay. At 5 years postoperatively, efficacy was comparable between arms. No differences were detected in safety outcomes except that the clot retention rate was significantly greater after M-TURP. CONCLUSION: Our results indicate that PK-TURP is equally as effective in the treatment of BPO, but has a more favorable safety profile in comparison to M-TURP. The clinical efficacy of PK-TURP is long-lasting and comparable with M-TURP.

Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis.

OBJECTIVE: The purpose of this study was to demonstrate omentin-1 levels in serum and synovial fluid (SF) of patients with knee osteoarthritis (OA) and to investigate their correlation with radiographic disease severity. METHODS: One hundred and ninety-seven patients with OA and 65 sex- and age-matched healthy controls were enrolled in this study. The radiographic disease severity of OA was assessed by the Kellgren- Lawrence (KL) grading system. The omentin-1 levels in serum and SF were determined by enzyme-linked immunosorbent assay. RESULTS: There were no significant differences in serum omentin-1 levels between patients with OA and healthy controls (P>0.05). There were also no significant differences in serum omentin-1 levels among patients with OA with different KL grades (P>0.05). However, SF omentin-1 levels decreased significantly as the KL grades increased (KL grade 4 < KL grade 3 < KL grade 2; all P<0.01) in the patients with OA. Furthermore, SF omentin-1 levels were negatively correlated with KL grades (r=-0.643; P<0.001). Multinomial logistic regression analysis revealed that there was still a negative correlation between the SF omentin-1 levels and the KL grades after adjusting for confounding factors (P<0.001). CONCLUSIONS: Synovial fluid omentin-1 levels showed an independent and negative correlation with radiographic severity of the disease in patients with knee OA. Omentin-1 in SF might serve as a potential biomarker for reflecting the degenerative process of primary knee OA.

HIV-infection resistance in PMBC-derived dendritic cells modified with recombinant virus.

This study aimed to identify the characteristics of recombinant-adenovirus-modified PBMC-derived dendritic cells and their resistance to HIV-1 infection by integrating the CCR5∆32, CCR5siRNA, HIV-1 pol and HIV-1 int genes into a recombinant adenovirus vector using the AdEasy system. Dendritic cells (DCs) were isolated from human PBMCs from blood of healthy donors. The expression of CCR5∆32, CCR5, CXCR4 and HIV-1 p24 in PBMCs or modified cells was measured by western blot, p24 expression in cell lysates was measured by ELISA, and HIV-1 entry was measured by ß-galactosidase assay. Furthermore, T-cell immunity induced by the recombinant adenovirus was measured by ELISPOT assay. After the cells were modified by Ad-R5∆32siRNA, the expression of CCR5∆32 increased, while the expression of CCR5 and CXCR4 decreased. There was no adverse effect of adenoviral gene transfer on DC development. CD83 expression on the surface of mature DCs did not change after gene transfer. The expression of p24 remained at low levels in modified cells when challenged by HIV-1. The modified cells showed resistance to HIV-1 infection. Results indicated that recombinant-adenovirus-modified cells demonstrated good resistance to HIV-1 infection. Modification of HSC-derived immune cells, such as DCs, may be a potent strategy to resist HIV-1 infection.

Association of FAS and FAS ligand polymorphisms with the susceptibility and severity of lumbar disc degeneration in Chinese Han population.

CONTEXT: Apoptosis is involved in the mechanism of lumbar disc degeneration (LDD). OBJECTIVE: We aim to determine whether the polymorphisms of FAS and FASL are associated with the presence and severity of LDD. METHODS: A total of 348 patients with LDD and 215 healthy controls were genotyped. RESULTS: Patients with LDD showed higher frequency of-1377GA and AA, as well as-844CT and TT genotypes than normal controls. These genotypes were found to be associated with the risk of higher grades of LDD. CONCLUSION: The polymorphisms of FAS and FASL may be associated with the presence and severity of LDD.